Back to search

National and Kapodistrian University of Athens

Ο ρόλος της εψιδίνης στην ερυθροποίηση μετά τη χορήγηση ενδοφλέβιου καρβοξυμαλτοζικού σιδήρου σε ασθενείς με ΧΝΝ

Abstract

dc:description

No reliable biomarker exists to predict responsiveness to intravenous (IV) iron (Fe) in iron decient patients with CKD. We aimed to investigate the clinical value of bioactive Hepcidin-25 and soluble Transferrin Receptor (sTfR) levels in predialysis patients. Patients and methods:In this prospective study 78 stable stage III-IV CKD predialysis patients with (responders) (40patients) and without (non-responders) (38patients) adequate erythropoiesis after IV administration of ferric-carboxymaltose (FCM). Patients were divided in two groups according to their response to IV administration of ferriccarboxymaltose (FCM). Along with measurements of common hematologic and blood chemistry parameters, determinations of sTfR and bioactive Hepcidin-25 were performed.Hepcidin-25 levels were lower in the responders (p = 0.025), while sTfR and sTfR/Hepcidin-25 ratio were higher (p b 0.01 and p = 0.002 respectively). Diagnostic efcacy indicated cut off point of 1.49 for Hepcidin-25 had sensitivity 84% and specicity 48%, while cut off point of 1.21 for sTfR/Hepcidin -25 ratio had sensitivity 82% and specicity 52% to predict correctly response to iron supplementation therapy. Furthermore, log sTfR/Hepcidin-25 correlated negatively with hs-CRP (p = 0.005) and IL-6 (p b 0.04) in non-responders, while suchcorrelations were not foundinresponders(p N 0.05). These results suggest that lower Hepcidin-25,as well as higher sTfR and sTfR/Hepcidin-25 ratio were signicant predictors of favorable hemoglobin response within a month after IV administration of FCM in patients with CKD.Further experiments and clinical studies in other groups of patients are needed to better elucidate the role of Hepcidin-25 and sTfR/Hepcidin-25 ratio as predictors of response to intravenous iron administration.

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2019

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Drakou, Athina
  • Δράκου, Αθηνά

Subjects

dc:subject × 10

Rights

dc:rights
Statement dc:rights
  • BY
Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/46455

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Drakou, Athina; Δράκου, Αθηνά. Ο ρόλος της εψιδίνης στην ερυθροποίηση μετά τη χορήγηση ενδοφλέβιου καρβοξυμαλτοζικού σιδήρου σε ασθενείς με ΧΝΝ. National and Kapodistrian University of Athens, 2019. http://hdl.handle.net/10442/hedi/46455